These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5913352)

  • 1. [Studies on the pupillary reaction in the course of a psychotropic treatment].
    Popkowska N
    Neurol Neurochir Psychiatr Pol; 1966 Feb; 16(2):167-71. PubMed ID: 5913352
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative results of pharmacologic loading with aminazine and heloperidol in the treatment of the simple form of schizophrenia (according to pain sensography findings)].
    Almazov BN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(9):1397-1401. PubMed ID: 4423309
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
    Radzuweit H; Knorr W
    Endokrinologie; 1969; 54(1):111-7. PubMed ID: 5358570
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Updating haloperidol: 1975].
    Ayd FJ
    Acta Physiol Lat Am; 1978 Sep; 24(3):233-8. PubMed ID: 751446
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
    Máthé V; Kassay G; Tüske M
    Int Pharmacopsychiatry; 1971; 6(2):111-30. PubMed ID: 4147757
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
    Rompel H; Segal H
    J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Depot-neuroleptics in the treatment of schizophrenia].
    Schipper JA
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427
    [No Abstract]   [Full Text] [Related]  

  • 12. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphologic anomalies of lymphocytes in schizophrenic patients in relation to various therapeutic methods].
    Belloni F
    Acta Neurol (Napoli); 1967; 22(5):689-700. PubMed ID: 5608897
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive abnormality in schizophrenia: a dual-process model.
    Kay SR; Singh MM
    Biol Psychiatry; 1979 Feb; 14(1):155-76. PubMed ID: 420899
    [No Abstract]   [Full Text] [Related]  

  • 15. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo differentiation of cardiac vagal blocking effects of chlorpromazine and haloperidol.
    Schreiber G; Belmaker RH
    Biol Psychiatry; 1987 Nov; 22(11):1417-21. PubMed ID: 3663793
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of acute and chronic psychoses with haloperidol: review of clinical results.
    Ban TA
    Curr Ther Res Clin Exp; 1969 May; 11(5):284-8. PubMed ID: 4977400
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosocial profiles and efficacy of lithium treatment.
    Demers RG
    Dis Nerv Syst; 1971 Apr; 32(4):249-54. PubMed ID: 5089991
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine.
    Man PL; Chen CH
    Psychosomatics; 1973; 14(1):59-63. PubMed ID: 4605009
    [No Abstract]   [Full Text] [Related]  

  • 20. Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine.
    Gerstenzang ML; Krulisky TV
    Dis Nerv Syst; 1977 Aug; 38(8):581-3. PubMed ID: 328243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.